Laura Hamill

Former EVP, Worldwide Commercial Operations, Gilead

Laura J. Hamill has deep experience in the biopharmaceutical industry, with over 30 years of global commercial experience in a variety of executive leadership positions. Most recently, she served as Executive Vice President, Worldwide Commercial Operations, for Gilead Sciences, Inc., where she was accountable for 2,200 employees and $22 billion in annual revenue and led the global commercial strategic direction and long-term planning.

Over an 18-year career at Amgen, Laura held several executive roles in the United States and internationally. In her last role as Senior Vice President and General Manager of the US, she was responsible for $18 billion in annual revenue and managed a team of 2,000 employees across all of Amgen’s therapeutic areas. She also served as the Chairperson of Amgen’s Senior Women’s Leadership Council.

Ms. Hamill is currently a member of the Board of Directors for BB Biotech and Y-mAbs Therapeutics. Ms. Hamill holds a bachelor’s degree in business administration from the University of Arizona.